Search

  • First Round of Abstract Submission: March 05, 2026
  • Pre-Early Bird Ends: March 04, 2026
Millennium Hotel Paris Charles de Gaulle
2 Allée du Verger, 95700 Roissy-en-France
Email
heidi@d-rnd.com
Get Your Ticket
Past Events ▾

Abstract Submission

Agenda Topics

    • High Throughput Screening
    • Hit and Lead Identification
    • Assay Development
    • Lead Generation and Optimization
    • In Vivo and In Vitro Assays
    • Screening Compound Libraries
    • Synthetic Organic Chemistry
    • Computational Chemistry
    • Lead Optimization
    • Developing a Drug from
      an Optimized Lead
    • Structure based Drug Designing
    • Case studies of Successful Drugs
    • Pre-Clinical Research
    • Clinical Research
    • Artificial Intelligence
    • Pharmacophore & Virtual
      Screening

    • Ubiquitin-Induced Protein
      Degradation
    • Fragment-Based Drug Discovery
    • Kinase Inhibitor Chemistry
    • Macrocyclics & Constrained
      Peptides
    • Protein-Protein Interactions
    • Small Molecules for Immunology
      & Oncology
    • Encoded Libraries for Small
      Molecule Discovery
    • Lead Optimization for Drug
      Metabolism

    • Target Identification and
      Validation
    • Quantitation of Drug Effects
    • The Diversity of Molecular
      Drug Targets
    • Cell Signalling Modalities
    • Pharmacotherapy
    • Pharmacodynamics & Pharmacokinetics
    • Drug-Target Interactions
    • RNA as a Small Molecule Target

    • Preclinical Investigation
    • Clinical Investigation
    • Drug Application Review
    • Postmarketing Surveillance
    • Regulatory Process

    • Data Digitalization
    • AI: Networks and Tools
    • AI in the Lifecycle of
      Pharmaceutical Products
    • AI in Designing Drug Molecules
    • AI in de novo Drug Design
    • AI in Advancing Pharmaceutical
      Product Development
    • AI in Pharmaceutical Manufacturing
    • AI in Quality Control and Quality
      Assurance
    • AI in Clinical Trial Design
    • AI in Pharmaceutical Product
      Management
    • AI in Market Positioning
    • AI in Market Prediction and
      Analysis
    • AI in Product Cost
    • AI-based Nanorobots for Drug
      Delivery
    • AI in Combination Drug Delivery
      and Synergism/Antagonism Prediction
    • AI Emergence in Nanomedicine
    • Pharmaceutical Market of AI
    • Ongoing Challenges In Adopting AI:
      Leads on Ways to Overcome

Reasons to Submit Abstract

  • Opportunity to interact with an exceptional group of speakers, including federal officers and top-tier researchers from both industry and academia.
  • Broaden your horizons: the congress welcomes scientists, experts, technocrats, and researchers from developed and developing nations, offering a truly global perspective.
  • Share your expertise worldwide: contribute your research findings, teaching methods, and exemplary practices to advance knowledge dissemination on a global scale.
  • All accepted abstracts will be published.
  • Opportunity to publish a full-length article in a SCOPUS INDEXED Journal (subject to confirmation).

Guidelines for Abstract Submission

  • Title: Keep your title brief and descriptive to accurately represent your research.
  • Authors: List all authors and their affiliations, making sure to identify the presenting author.
  • Introduction: Clearly explain the background and objectives of your study, along with the motivation behind your research.
  • Methods: Describe the methods or approaches used in your study, including details about experimental design and data collection.
  • Results: Summarize the main findings of your study, supported by relevant data and statistical analyses.
  • Discussion: Interpret your results and discuss their implications, comparing them to previous research and suggesting areas for future study.
  • Conclusion: Summarize the main conclusions drawn from your study and explain their significance for the field.
  • Keywords: Include 3-5 keywords that highlight the main topics or concepts covered in your abstract.
  • Formatting: Follow the formatting guidelines provided by the organizer and proofread your abstract for errors.
  • Submission Instructions: Adhere to the submission deadlines and instructions provided by the organizer.
  • Ethical Considerations: Ensure that your research complies with ethical guidelines and regulations, providing any necessary information regarding ethical approval or informed consent.
  • Clarity and Conciseness: Keep your abstract clear, concise, and focused, avoiding unnecessary technical jargon or excessive detail.

General Guidelines for Lectures and Presentations

  • Keynote Talk: 30 mins; 25 mins presentation followed by 5 mins Q&A.
  • Invited Oral Talk: 20 mins; 17 mins presentation followed by 3 mins Q&A.
  • Podium Presentation: 15 mins; 12 mins presentation followed by 3 mins Q&A.
  • Flash Presentation: 10 mins; 8 mins presentation followed by 2 mins Q&A.

PowerPoint Format for Speakers

For optimal broadcasting, it's recommended to use the 16:9 format for your PowerPoint presentation. When converting from 4:3 to 16:9, ensure that figures maintain their original proportions and do not become stretched. If stretching occurs, utilize the option in the figure-size menu to restore the original size. Keep presentations light, clear, and concise by minimizing text, animations, and videos.

Register